Revolution in breast cancer detection: Tomosynthesis in the Zollernalbklinikum!

Innovative Tomosynthese verbessert die Brustkrebsfrüherkennung im Zollernalbklinikum. Erfahren Sie mehr über diese bahnbrechende Technologie und ihre Vorteile für Frauen.
Innovative Tomosynthesis improves breast cancer early detection in the Zollernalbklinikum. Learn more about this groundbreaking technology and your advantages for women. (Symbolbild/NAGW)

Revolution in breast cancer detection: Tomosynthesis in the Zollernalbklinikum!

breast cancer remains one of the most common cancer in women in Germany, especially over 50 year olds. Early detection is becoming increasingly important with more than 78,000 new illnesses annually because it significantly increases the chances of survival. In the Zollernalbklinikum, an innovative tomosynthesis procedure has been used for breast cancer early detection since May 2024. This procedure creates 3D images from 20 to 25 individual shots, which enables the possibility of more precise diagnostics. Professor Dr. Michael Bitzer, chief physician of Central Radiology, emphasizes the progress in mammography and emphasizes that this technology increases the rate of discovery by 20 to 30 percent compared to conventional mammographies.

women between the ages of 50 and 74 take part in the state mammography program, which provides for regular examinations every two years. Mammography is often used in women aged 40 and over, while ultrasound methods are often used in younger patients. In many cases, unclear findings lead to biopsies. Therefore, regular examinations are strongly recommended, because breast cancer can often arise within two years. Positive feedback from patients show that the Tomosynthesis is associated with a lower feeling of pressure and a better localization of the findings.

reliable artificial intelligence as support

The integration of artificial intelligence (AI) into mammography is considered a promising development. Studies, as that of Rodriguez-Ruiz et al. Your studies, published in the Journal of the National Cancer Institute 2019 and in other specialist journals, illustrate the positive influence of AI on breast cancer detection. In addition, the use of AI leads to a discovery rate of 6.7 cases per 1000 women compared to 5.7 cases without AI-based systems.

Another remarkable investigation, the Praim study, under the direction of Prof. Dr. Alexander Katalinic at the University of Lübeck and the University Hospital Schleswig-Holstein, also dealt intensively with the benefits of AI in mammography screening. This prospective study was able to see an almost 18 %increase in the discovery rate for breast cancer without the number of incorrect positive findings or unnecessary additional examinations.

future of early detection

In the Zollernalbklinikum, Priska Hauth leads a team of four people who is responsible for the Tomosynthesis shots. The radiation exposure caused by the Tomosynthesis corresponds to the values ​​of conventional mammography. Nevertheless, it is important that the assumption of costs by the health insurance company is often associated with an additional payment if there is no findings, but this is reimbursed in many cases. In view of the positive experiences from clinics and studies, experts believe that Tomosynthesis play an essential role in breast cancer early detection in the future and possibly completely replace mammography.

In summary, it turns out that both the Tomosynthesis and AI-based approaches are decisive for the further development of breast cancer early detection. These technologies not only offer more precise diagnoses, but could also notify the working load of radiologists noticeably.

For more information about the latest developments in breast cancer early detection, you can read the following articles: Schwäbische reports on the Tomosynthese , Siemens healthineers in the mammography The University of Lübeck informs about the praim-study .

Details
OrtBalingen, Deutschland
Quellen